Patil Sachin, Jain Sudhir, Kaza R C M, Chamberlain Ronald S
Department of Surgery, Saint Barnabas Medical Center, Livingston, NJ 07039, USA.
ISRN Surg. 2011;2011:894829. doi: 10.5402/2011/894829. Epub 2011 Jun 16.
Gastrointestinal stromal tumors (GIST-) account for the majority of mesenchymal tumors arising within the gastrointestinal tract. GIST presenting as a palpable abdominal mass is extremely rare. We report four additional cases of a GIST presenting as an abdominal mass along with a pertinent review of the literature. Twenty five cases of GISTs presenting with an abdominal mass, including 4 cases discussed here, have been reported in the world literature since 2001. The mean duration of symptoms was 152.7 days. Twenty one of 25 (84%) patients received surgical resection. The mean tumor size was 17.2 cm, with an average mitotic index of 7.6 per 50 high power fields. Thirteen of 14 (92.9%) patients had a high-risk tumor. Five patients were disease-free at a mean followup of 11 months, 2 patients had stable disease and 2 patients had progressive disease, and one patient had a partial response. In conclusion, symptomatic patents have an increased incidence of high-risk tumors and metastases at presentation. Adjuvant therapy with imatinib improves disease-free survival in patients with large abdominal GIST tumors, but no change in overall survival was noted. Finally, GISTs should be considered in the differential diagnosis of an abdominal mass in an elderly patient.
胃肠道间质瘤(GIST)占胃肠道间叶组织肿瘤的大多数。以可触及的腹部肿块形式出现的GIST极为罕见。我们报告另外4例以腹部肿块形式出现的GIST病例,并对相关文献进行综述。自2001年以来,世界文献中已报道25例以腹部肿块形式出现的GIST病例,包括此处讨论的4例。症状的平均持续时间为152.7天。25例患者中有21例(84%)接受了手术切除。肿瘤平均大小为17.2厘米,每50个高倍视野的平均有丝分裂指数为7.6。14例患者中有13例(92.9%)为高危肿瘤。5例患者在平均随访11个月时无疾病进展,2例患者病情稳定,2例患者病情进展,1例患者部分缓解。总之,有症状的患者在就诊时高危肿瘤和转移的发生率增加。伊马替尼辅助治疗可改善腹部GIST大肿瘤患者的无病生存期,但总体生存期无变化。最后,老年患者腹部肿块的鉴别诊断应考虑GIST。